Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress

被引:28
|
作者
Diz-Chaves, Yolanda [1 ]
Herrera-Perez, Salvador [2 ]
Gonzalez-Matias, Lucas C. [1 ]
Lamas, Jose Antonio [2 ]
Mallo, Federico [1 ]
机构
[1] Univ Vigo, Lab Endocrinol, CINBIO, Grp FB3A, Vigo 36310, Spain
[2] Univ Vigo, Lab Neurociencia, CINBIO, Grp FB3A, Vigo 36310, Spain
关键词
glucagon-like peptide-1; hypothalamic-pituitary-adrenal (HPA) axis; sympathetic nervous system (SNS); ion channels; food intake; BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL-AXIS; NUCLEUS-TRACTUS-SOLITARIUS; RECEPTOR-EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; PANCREATIC BETA-CELLS; REDUCES FOOD-INTAKE; HEART-RATE; ENERGY-BALANCE;
D O I
10.3390/nu12113304
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Glucagon like-peptide 1 (GLP-1) within the brain is produced by a population of preproglucagon neurons located in the caudal nucleus of the solitary tract. These neurons project to the hypothalamus and another forebrain, hindbrain, and mesolimbic brain areas control the autonomic function, feeding, and the motivation to feed or regulate the stress response and the hypothalamic-pituitary-adrenal axis. GLP-1 receptor (GLP-1R) controls both food intake and feeding behavior (hunger-driven feeding, the hedonic value of food, and food motivation). The activation of GLP-1 receptors involves second messenger pathways and ionic events in the autonomic nervous system, which are very relevant to explain the essential central actions of GLP-1 as neuromodulator coordinating food intake in response to a physiological and stress-related stimulus to maintain homeostasis. Alterations in GLP-1 signaling associated with obesity or chronic stress induce the dysregulation of eating behavior. This review summarized the experimental shreds of evidence from studies using GLP-1R agonists to describe the neural and endocrine integration of stress responses and feeding behavior.
引用
收藏
页码:1 / 32
页数:32
相关论文
共 50 条
  • [41] CLONING AND FUNCTIONAL EXPRESSION OF THE HUMAN GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR
    DILLON, JS
    TANIZAWA, Y
    WHEELER, MB
    LENG, XH
    LIGON, BB
    RABIN, DU
    YOOWARREN, H
    PERMUTT, MA
    BOYD, AE
    ENDOCRINOLOGY, 1993, 133 (04) : 1907 - 1910
  • [42] Comparison of efficacy of weekly glucagon-like peptide-1 (GLP-1) analogue therapies
    Thant, A. A.
    Atkinson, R.
    Kapoor, A.
    Lowe, G.
    Basu, A.
    Bharaj, H.
    Basu, A.
    Banerjee, M.
    DIABETIC MEDICINE, 2021, 38
  • [43] Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
    Basalay, Maryna V.
    Davidson, Sean M.
    Yellon, Derek M.
    NEURAL REGENERATION RESEARCH, 2020, 15 (10) : 1852 - 1853
  • [44] Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor
    Helmstaedter, Johanna
    Keppeler, Karin
    Kuester, Leonie
    Muenzel, Thomas
    Daiber, Andreas
    Steven, Sebastian
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 659 - 676
  • [45] The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction
    Shannon, Maeve
    Green, Brian
    Willars, Gary
    Wilson, Jodie
    Matthews, Natalie
    Lamb, Joanna
    Gillespie, Anna
    Connolly, Lisa
    TOXICOLOGY LETTERS, 2017, 265 : 97 - 105
  • [46] Addition of a cysteine to glucagon-like peptide-1 (GLP-1) conjugates GLP-1 to albumin in serum and prolongs GLP-1 action in vivo
    Wu, Ye-Lin
    Huang, Jing
    Xu, Jin
    Liu, Jian
    Feng, Zhen
    Wang, Yang
    Lai, Yuping
    Wu, Zi-Rong
    REGULATORY PEPTIDES, 2010, 164 (2-3) : 83 - 89
  • [47] Glucagon-like peptide 1 (GLP-1) and metabolic diseases
    C. M. Rotella
    L. Pala
    E. Mannucci
    Journal of Endocrinological Investigation, 2005, 28 : 746 - 758
  • [48] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [49] Glucagon-like peptide 1 (GLP-1) in diabetes and aging
    D'Alessio, D
    JOURNAL OF ANTI-AGING MEDICINE, 2000, 3 (03): : 329 - 333
  • [50] Glucagon-like peptide 1(GLP-1) in biology and pathology
    Meier, JJ
    Nauck, MA
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) : 91 - 117